Senti Biosciences, Inc.SNTINASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+9.5%
5Y CAGR+18.3%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+9.5%/yr
Annual compound
5Y CAGR
+18.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$36.91M+7.4%
2024$34.36M+6.9%
2023$32.15M+14.2%
2022$28.14M+28.2%
2021$21.96M+37.6%
2020$15.96M+9.9%
2019$14.52M-